Currently set to Index
Currently set to Follow
ask age2b

β-Galactooligosaccharide in Conjunction With Low FODMAP Diet Improves Irritable Bowel Syndrome Symptoms but Reduces Fecal Bifidobacteria

By AGE2B team
June 30, 2021

Main idea: The LFD combined with B-GOS prebiotic produced a greater symptom response than the sham diet plus placebo, but the addition of 1.4 g/d B-GOS did not prevent the reduction of bifidobacteria. The LFD reduces fecal Actinobacteria and butyrate thus strict long-term use should not be advised.


The low FODMAP diet (LFD) reduces symptoms and bifidobacteria in irritable bowel syndrome (IBS). β-galactooligosaccharides (B-GOS) may reduce the symptoms and increase bifidobacteria in IBS. We investigated whether B-GOS supplementation alongside the LFD improves IBS symptoms while preventing the decline in bifidobacteria. The clinical trial was performed. Patients were randomized to a sham diet with placebo supplement (control) or LFD supplemented with either placebo (LFD) or 1.4 g/d B-GOS (LFD/B-GOS) for 4 weeks. At 4 weeks adequate symptom relief was higher in the LFD/B-GOS group than in the control group; Bifidobacterium concentrations were the same between LFD and LFD/B-GOS, but were lower in the LFD/B-GOS than in the control. The proportion of Actinobacteria was lower in LFD and LFD/B-GOS groups than in the control group. Fecal butyrate was lower in the LFD and LFD/B-GOS groups than in the control group.

Source AJG

Leave a Reply

Ask your question

We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community

Please complete the required fields.